Pure Global

REPİGO 200 MG I.M./I.V. POWDER AND SOLVENT FOR THE PREPARATION OF SOLUTION FOR INJECTION, 1 VIAL AND 1 AMPOULE - Turkey License ade2606063a9c6b5d2399b2e69f4b9d5

Access comprehensive regulatory information for REPİGO 200 MG I.M./I.V. POWDER AND SOLVENT FOR THE PREPARATION OF SOLUTION FOR INJECTION, 1 VIAL AND 1 AMPOULE in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number ade2606063a9c6b5d2399b2e69f4b9d5 with license number 2022/354and contains active ingredient Teicoplanin. The license is held by DEVA HOLDİNG A.Ş..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
21,000+ Products
ade2606063a9c6b5d2399b2e69f4b9d5
License Details
Turkey SFDA License: ade2606063a9c6b5d2399b2e69f4b9d5
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Product Details

REPİGO 200 MG I.M./I.V. POWDER AND SOLVENT FOR THE PREPARATION OF SOLUTION FOR INJECTION, 1 VIAL AND 1 AMPOULE
TR: REPİGO 200 MG I.M./I.V. ENJEKSİYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN TOZ VE ÇÖZÜCÜ, 1 FLAKON VE 1 AMPUL
Pharmaceutical Product

License Details

ade2606063a9c6b5d2399b2e69f4b9d5

2022/354

8699525798527

J01XA02

License Holder Information

Active Ingredient

Teicoplanin

License Information

Jun 30, 2022